InnoPharmaScreen(IPS) Inc., was established in 2009, offers an innovative approach for a novel drug discovery by using an Integrated Drug Discovery Platform (IDDP) that involves ‘structure-based in silico drug design, ‘IPS Chip- based high performance screening,‘Cell based-Bioassay' including lead optimization. IDDP technology dealing with a number of biologically relevant targets focusing on PPI for different therapeutic applications including Immuno-Oncology and orphan inflammatory diseases.